GlassScriptPhysician profile
Chad J Cooper
NPI 1770876229
$5,198.59
in general payments reported to CMS, 2019-2025
20 companies · $286 in 2025
The $286 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,585 · 2020: $409 · 2021: $435 · 2022: $590 · 2023: $445 · 2024: $448 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,179.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $2,262.55 | 2019 | |
| Abbvie INC. | $1,051.42 | 2019-2025 | Skyrizi, Rinvoq, Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $568.48 | 2019-2025 | Entyvio, Eohilia |
| Gilead Sciences, INC. | $319.58 | 2020-2025 | |
| Olympus America INC. | $236.84 | 2019-2024 | Endoclot Phs |
| Genzyme Corporation | $145.99 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $139.69 | 2023-2024 | Dupixent |
| Janssen Biotech, INC. | $103.50 | 2019-2022 | |
| Allergan, INC. | $57.07 | 2020 | |
| Braintree Laboratories, INC. | $53.32 | 2019 | |
| Pfizer INC. | $47.10 | 2025 | |
| Phathom Pharmaceuticals, INC. | $46.54 | 2024 | Voquezna |
| Mauna Kea Technologies, INC. | $33.06 | 2021 | |
| Ucb, INC. | $24.86 | 2019 | |
| Qol Medical, LLC | $23.49 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $20.22 | 2022 | |
| Daiichi Sankyo INC. | $19.74 | 2020 | |
| Boston Scientific Corporation | $16.73 | 2021 | |
| Intercept Pharmaceuticals, INC. | $16.55 | 2024 | |
| Merck Sharp & Dohme LLC | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.